Importance of Balanced Attention Toward Coronavirus Disease 2019 and Neglected Tropical Diseases

키워드

참고문헌 (68)

1. Zhu N, "A novel coronavirus from patients with pneumonia in China, 2019", N Engl J Med, 382, pp.727~733 (2020)
2. Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
3. Johnson KD, "Pulmonary and extra-pulmonary clinical manifestations of COVID-19", Front Med(Lausanne), 7, pp.526~ (2020)
4. Gupta A, "Extrapulmonary manifestations of COVID-19", Nat Med, 26, pp.1017~1032 (2020)
5. Utzinger J, "Neglected tropical diseases : diagnosis, clinical management, treatment and control", Swiss Med Wkly, 142, pp.w13727~ (2012)
6. Chanda-Kapata P, "Tuberculosis, HIV", AIDS and malaria health services in sub-Saharan Africa–a situation analysis of the disruptions and impact of the COVID-19 pandemic, 2022, pp.124, S41~S46
7. Bell D, "Relative burdens of the COVID-19, malaria, tuberculosis, and HIV", AIDS epidemics in sub-Saharan Africa, 2021, pp.105, 1510~1515
8. "Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria–a systematic review" (2022)[URL]
9. Miguel DC, "The impact of COVID-19 on neglected parasitic diseases : what to expect?", Trends Parasitol, 37, pp.694~697 (2021)
10. Wolday D, "Effect of co-infection with intestinal parasites on COVID-19 severity : a prospective observational cohort study", EClinicalMedicine, 39, pp.101054~ (2021)
11. Tilli M, "Neglected tropical diseases in non-endemic countries in the era of COVID-19 pandemic : the great forgotten", J Travel Med, 28, pp.taaa179~ (2021)
12. Akelew Y, "Immunomodulation of COVID-19 severity by helminth co-infection : implications for COVID-19 vaccine efficacy", Immun Inflamm Dis, 10, pp.e573~ (2022)
13. Bradbury RS, "Will helminth co-infection modulate COVID-19 severity in endemic regions?", Nat Rev Immunol, 20, pp.342~ (2020)
14. Abdoli A, "Helminths and COVID-19 co-infections : a neglected critical challenge", ACS Pharmacol Transl Sci, 3, pp.1039~1041 (2020)
15. Chacon N, "Implications of helminth immunomodulation on COVID-19 co-infections", Life Res, 4, pp.26~ (2021)
16. "NTDs: countries must adapt and innovate to mitigate COVID-19 disruptions"[URL]
17. The expanded special project for elimination of neglected tropical diseases(ESPEN)2017 annual report, "World Health Organization", World Health Organization, ~ (2018)
18. Ng’etich AKS, "Development and validation of a framework to improve neglected tropical diseases surveillance and response at sub-national levels in Kenya", PLoS Negl Trop Dis, 15, pp.e0009920~ (2021)
19. Aagaard-Hansen J, "Equity, social determinants and public health programmes", pp.135~158 (2010), World Health Organization
20. Kabore A, "Restarting neglected tropical diseases programs in West Africa during the COVID-19 pandemic : lessons learned and best practices", Am J Trop Med Hyg, 105, pp.1476~1482 (2021)
21. McKay S, "Safely resuming neglected tropical disease control activities during COVID-19 : perspectives from Nigeria and Guinea", PLoS Negl Trop Dis, 15, pp.e0009904~ (2021)
22. Nghochuzie NN, "Pausing the fight against malaria to combat the COVID-19 pandemic in Africa : is the future of malaria bleak?", Front Microbiol, 11, pp.1476~ (2020)
23. "NTDs: pulse survey shows COVID-19continues to disrupt health services"[URL]
24. Gutman JR, "Malaria and parasitic neglected tropical diseases : potential syndemics with COVID-19?", Am J Trop Med Hyg, 103, pp.572~577 (2020)
25. Weiss DJ, "Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa : a geospatial modelling analysis", Lancet Infect Dis, 21, pp.59~69 (2021)
26. "Global spending on health: weathering the storm"[URL]
27. "UK Coalition against NTDs statement on cuts to UK Official Development Aid"[URL]
28. "Neglected Disease Research and Development: New Perspectives"[URL]
29. Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China", JAMA, 323, pp.1061~1069 (2020)
30. Chacin-Bonilla L, "Emerging issues in COVID-19 vaccination in tropical areas : impact of the immune response against helminths in endemic areas", Travel Med Infect Dis, 42, pp.102087~ (2021)
31. Rolot M, "Helminth-induced IL-4 expands bystander memory CD8+ T cells for early control of viral infection", Nat Commun, 9, pp.4516~ (2018)
32. Brosschot TP, "The impact of a helminth-modified microbiome on host immunity", Mucosal Immunol, 11, pp.1039~1046 (2018)
33. Roe K, "The link between Toxoplasma gondii infections and higher mortality in COVID-19 patients having schizophrenia", Eur Arch Psychiatry Clin Neurosci, 272, pp.167~168 (2022)
34. Roe K, "The role of polyspecific T-cell exhaustion in severe outcomes for COVID-19 patients having latent pathogen infections such as Toxoplasma gondii", Microb Pathog, 161(Pt B), pp.105299~ (2021)
35. Correia MJ, "A patient with severe malaria and COVID-19 : how do you tell the difference between these infections?", Eur J Case Rep Intern Med, 7, pp.002007~ (2020)
36. Suarez I, "Malaria and COVID-19in an indigenous patient, overlapping of two febrile illnesses", J Microbil Infect Dis, 12, pp.27~30 (2022)
37. Eshaghi H, "Clinical misdiagnosis of COVID-19 infection with confusing clinical course", Case Rep Infect Dis, 2021, pp.6629966~ (2021)
38. "Visceral leishmaniasis in an Ethiopian patient with COVID-19: a case report. Research Square" (2020)[URL]
39. Mahajan NN, "Co-infection of malaria and dengue in pregnant women with SARS-CoV-2", Int J Gynaecol Obstet, 151, pp.459~462 (2020)
40. Abdoli A, "COVID-19-associated opportunistic infections : a snapshot on the current reports", Clin Exp Med, 22, pp.327~346 (2022)
41. Lier AJ, "Case report : disseminated strongyloidiasis in a patient with COVID-19", Am J Trop Med Hyg, 103, pp.1590~1592 (2020)
42. Marchese V, "Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia", Infection, 49, pp.539~542 (2021)
43. Norman FF, "Strongyloides in bronchoalveolar lavage fluid : practical implications in the COVID-19 era", J Travel Med, 29, pp.taab114~ (2022)
44. Kim JM, "Strongyloides hyperinfection syndrome among COVID-19 patients treated with corticosteroids", Emerg Infect Dis, 28, pp.1531~1533 (2022)
45. Geri G, "Strongyloides stercoralis hyperinfection syndrome : a case series and a review of the literature", Infection, 43, pp.691~698 (2015)
46. Mejia R, "Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis", Curr Opin Infect Dis, 25, pp.458~463 (2012)
47. Requena-Méndez A, "Evidence-based guidelines for screening and management of strongyloidiasis in non-endemic countries", Am J Trop Med Hyg, 97, pp.645~652 (2017)
48. Rezapour R, "The impact of the Covid-19 pandemic on primary health care utilization : an experience from Iran", BMC Health Serv Res, 22, pp.404~ (2022)
49. Shaaban AN, "COVID-19 : what is next for Portugal?", Front Public Health, 8, pp.392~ (2020)
50. Mulu A, "The challenges of COVID-19 testing in Africa : the Ethiopian experience", Pan Afr Med J, 38, pp.6~ (2021)
51. Siddiqui AF, "Situation of India in the COVID-19 pandemic : India's initial pandemic experience", Int J Environ Res Public Health, 17, pp.8994~ (2020)
52. Paniz-Mondolfi AE, "The arrival of SARSCoV-2 in Venezuela", Lancet, 395, pp.e85~e86 (2020)
53. Cuadros DF, "Dynamics of the COVID-19 epidemic in urban and rural areas in the United States", Ann Epidemiol, 59, pp.16~20 (2021)
54. Faggioni MP, "National health system cuts and triage decisions during the COVID-19 pandemic in Italy and Spain : ethical implications", J Med Ethics, 47, pp.300~307 (2021)
55. Hendarwan H, "Assessing the COVID-19 diagnostic laboratory capacity in Indonesia in the early phase of the pandemic", WHO South East Asia J Public Health, 9, pp.134~140 (2020)
56. Salari N, "The prevalence of stress, anxiety and depression within front-line healthcare workers caring for COVID-19 patients : a systematic review and meta-regression", Hum Resour Health, 18, pp.100~ (2020)
57. Tuczyn´ska M, "Accessibility to non-COVID health services in the world during the COVID-19pandemic : review", Front Public Health, 9, pp.760795~ (2021)
58. "The Global Health Observatory"[URL]
59. Hogan AB, "Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries : a modelling study", Lancet Glob Health, 8, pp.e1132~e1141 (2020)
60. "Impact of Covid-19 pandemic extends to tuberculosis and neglected tropical diseases"[URL]
61. Akinokun RT, "The status of neglected tropical diseases amidst COVID-19 in Africa : current evidence and recommendations", Health Promot Perspect, 11, pp.430~433 (2021)
62. "Ending neglected tropical diseases to build a better, fairer, healthier world"[URL]
63. "COVID-19 pandemic drains resources for neglected diseases"[URL]
64. Aborode AT, "Fighting COVID-19 at the expense of malaria in Africa : the consequences and policy options", Am J Trop Med Hyg, 104, pp.26~29 (2021)
65. Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021–2030, "World Health Organization", World Health Organization, ~ (2021)
66. Redekop WK, "The socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases", PLoS Negl Trop Dis, 11, pp.e0005289~ (2017)
67. "We can win the fight against tropical diseases in our lifetime - if we make the right decisions now"[URL]
68. "Country leadership and collaboration on neglected tropical diseases: third progress report of the London declaration"[URL]

관련 논문AI추천